NACDS names new political affairs chief to spearhead political action, fundraising
ALEXANDRIA, Va. Bolstering its political clout on Capitol Hill, the National Association of Chain Drug Stores has hired lobbying veteran J. Anne Foley as its new director of political affairs. Foley will lead NACDS’ proactive political programs, including the bipartisan NACDS Political Action Committee, or NACDS-PAC, which supports the U.S. congressional campaigns of pro-pharmacy members of Congress and candidates.
Foley comes to NACDS from the Credit Union National Association, where she managed its political programs. She also has worked for the National Mining Association in government and political affairs.
At NACDS, Foley will report to Paul Kelly, VP federal affairs. Among her prime objectives: boosting the organization’s fundraising abilities through its PAC, finding new opportunities for NACDS-PAC to work with other endeavors at NACDS and helping to raise the association’s political visibility at the federal and state levels.
“Anne’s expertise in managing political programs, as well as her political advocacy and fundraising experience, will help to further engage NACDS members politically to achieve pro-patient, pro-pharmacy policies,” said NACDS president and CEO Steven Anderson. He added that the group “is committed to building on the remarkable momentum of NACDS-PAC, which set its new fundraising record in 2009 – a solid accomplishment in a nonelection year.”
“With 30% of contributions from new participants, the growth and future potential of NACDS-PAC is strong,” Anderson added. He also hinted that more news from NACDS’ political front will come soon, noting, “We look forward to making another announcement regarding NACDS’ political engagement during the upcoming NACDS Pharmacy and Technology Conference, Aug. 28-31.”
Survey: Adolescent vaccination on the rise
ATLANTA A recent survey out of the Centers for Disease Control and Prevention found that adolescent vaccination at the national, state and selected local area levels are all on the rise.
Continued increases — as much as 15% — were made in nationwide coverage for vaccines specifically recommended for pre-teens, according to 2009 National Immunization Survey-Teen estimates released Thursday by the CDC.
The survey of more than 20,000 teens ages 13 to 17 years found that in 2009 there were increases in the percentage of teens in this age group who had received vaccines routinely recommended for 11- and 12-year-olds. Specifically:
• For one dose of the tetanus-diphtheria-acellular pertussis vaccine, coverage went up about 15 points to about 56%; • For one dose of meningococcal conjugate vaccine, coverage went up about 12 points to about 54%; • For girls who received at least one dose of human papillomavirus vaccine, coverage increased 7 points to about 44%. However, for girls who received the recommended three doses of HPV vaccine, coverage was only about 27% (a 9% increase);
"This year’s data are mixed," stated Anne Schuchat, director of the CDC’s National Center for Immunization and Respiratory Diseases. "We can see that more parents of adolescents are electing to protect their children from serious diseases such as pertussis, meningitis and cervical cancer, but there is clear room for improvement in our system’s ability to reach this age group."
"Pertussis outbreaks in several states and an increase in pertussis-related infant deaths in California highlight how important it is for pre-teens to receive the Tdap booster," Schuchat added. "It is important for teens and adults to get a one-time dose of Tdap to protect themselves and those around them from whooping cough. Young infants are most vulnerable to serious complications from pertussis and can be infected by older siblings, parents or other caretakers."
RediClinic announces availability of FluMist
HOUSTON RediClinic, which operates more than 20 clinics in H-E-B grocery stores in Houston and Austin, Texas, has announced the availability of FluMist at its clinics for the 2010-2011 flu season.
The clinic also soon will offer the flu shot Fluvirin, which is given with a needle and approved for use in people 4 years of age and older, including healthy people and people with chronic medical conditions, the clinic operator stated.
FluMist, which currently is available in a limited supply, is a needle-free, nasal-spray flu vaccine. FluMist is approved for use in healthy people 2 to 49 years of age who are not pregnant.